Literature DB >> 9644118

The United Kingdom's hepatitis B immunisation strategy--where now?

D Goldberg1, J McMenamin.   

Abstract

The World Health Organization recommended in 1992 that all countries should introduce universal hepatitis B vaccination into their immunisation schedules by December 1997. Over 80 countries, many of them in western Europe, have complied with the recommendation, but, in the United Kingdom (UK), hepatitis B vaccine is offered to selected high risk population groups only. Vaccination uptake in many of these groups is poor and transmission of hepatitis B remains a problem. The current incidence of hepatitis B is lower in the UK than in countries that have adopted a universal approach. It is impossible, however, to predict the number of acute infections that might occur in an unvaccinated teenage population in the year 2015 if the UK's current strategy remains unaltered. Universal immunisation would guarantee that hundreds, if not thousands, of acute illnesses and an appreciable number of severe outcomes would be prevented each year. The authors believe that funding this intervention would be money well spent.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9644118

Source DB:  PubMed          Journal:  Commun Dis Public Health        ISSN: 1462-1843


  7 in total

1.  Overcoming barriers to hepatitis B immunisation by a dedicated hepatitis B immunisation service.

Authors:  V F Larcher; J Bourne; C Aitken; D Jeffries; D Hodes
Journal:  Arch Dis Child       Date:  2001-02       Impact factor: 3.791

2.  Hepatitis B immunisation of household contacts: retrospective study of vaccine coverage.

Authors:  G Richardson; M R Evans; D Westmoreland
Journal:  J Epidemiol Community Health       Date:  2001-12       Impact factor: 3.710

Review 3.  Understanding correlates of hepatitis B virus vaccination in men who have sex with men: what have we learned?

Authors:  L J Yee; S D Rhodes
Journal:  Sex Transm Infect       Date:  2002-10       Impact factor: 3.519

4.  HPV vaccine: positive insights from universal adolescent HepB vaccination.

Authors:  J Claire Cameron; Lesley A Wallace; Syed Ahmed; Rina Duff; Martin Donaghy; David J Goldberg
Journal:  J Epidemiol Community Health       Date:  2007-12       Impact factor: 3.710

5.  The economic burden of hepatitis B in Germany.

Authors:  S Harbarth; T Szucs; K Berger; W Jilg
Journal:  Eur J Epidemiol       Date:  2000-02       Impact factor: 8.082

6.  Hepatitis B virus infection among Chinese residents in the United Kingdom.

Authors:  M Kawsar; B T Goh
Journal:  Sex Transm Infect       Date:  2002-06       Impact factor: 3.519

7.  Problem drug use the public health imperative: what some of the literature says.

Authors:  Gez Bevan
Journal:  Subst Abuse Treat Prev Policy       Date:  2009-12-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.